How do you decide when to escalate hepatic encephalopathy–directed therapy versus prioritize evaluation/treatment of non-HE contributors (sleep disorder, depression/anxiety, constipation, sarcopenia) in a decompensated cirrhosis patient with prior overt HE and persistently high fatigue/sleep symptom burden but only mild hyperammonemia?